China-Gel (China Gel) – contamination risk (2021)
Class II: A situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Class II recall indicates potential for temporary health effects.
This AI-generated summary is provided for general informational purposes only and is derived from publicly available recall notices. It supplements but does not replace official agency classifications or safety instructions.
Check Your Product
According to the U.S. Food and Drug Administration (FDA)
Product
CHINA_GEL (Camphor 3.00%, Menthol 5.00%) A TOPICAL PAIN RELIEVER, packaged as a) 2 OZ (56.8g) tube, NDC 76305-300-13; b) 4 OZ (113.5g) jar, UPC 6 87806 10004 2, NDC 76305-300-02; c) 6 OZ (170 g) tube, UPC 6 87806 10006 2, NDC 76305-300-03; d) 8 OZ (226.8g) jar, UPC 6 87806 10008 2, NDC 76305-300-04; e) 16 OZ (453.6g), Bottle w/ Pump, UPC 6 87806 10016 7, NDC 76305-300-03; f) 128 OZ (3.78L) Gallon, UPC 6 87806 10128 7, NDC 76305-300-06; Distributed by: CHINA-GEL LLC, Arlington Height
Brand
China Gel Inc
Lot Codes / Batch Numbers
Lot #: a)B122DY, exp 2021-05, B183GN, exp 2021-07, B262BF, exp 2021-09, C002KF, exp 2022-01, C030HT, exp 2022-02, C094LT, exp 2022-04, C275CW, exp 2022-10, C338CH, exp 2022-12, b) B122DX, exp 2021-05, B183GP, exp 2021-07, B262BE, exp 2021-09, C002KF, exp 2022-01, C030HT, exp 2022-02, C094LT, exp 2022-04, C275CW, exp 2022-10, C330BG, exp 2022-12 c) B122DY, exp 2021-05, B183GN, exp 2021-07, B262BF, exp 2021-09, C002KF, exp 2022-01, C030HT, exp 2022-02, C094LT, exp 2022-04, C156FF, exp 2022-06, C247JB, exp 2022-09, C338CH, exp 2022-12. d)B122DX, Exp 05/2021, B122DY, EXP 05-2021, B183GP, EXP 07-2021, B262BE, EXP 09-2021, B262BF, EXP 09-2021, C002KF, EXP 01-2022, C030HT, EXP 02-2022, C094LT, EXP 04-2022, C156FF, EXP 06-2022, C247JB, EXP 09-2022, C275CW, EXP 10-2022, C330BG, EXP 12-2022, e) B100JS, Exp 04/2021, B183GQ, EXP 07-2021, B255KZ, EXP 09-2021, C030HS, EXP 02-2022, C100AH, EXP 04-2022, C247JF, EXP 09-2022, f) B122DY, EXP 05-2021, B183GN, EXP 07-2021, B183GP, EXP 07-2021, B262BF, EXP 01-2022, C002KF, EXP 02-2022, C030HT, EXP 02-2022, C094LT, EXP 04-2022, C156FF, EXP 09-2022, C275CW, EXP 12-2022, C338CH, EXP 05-2022
Products Sold
Lot #: a)B122DY, exp 2021-05; B183GN, exp 2021-07; B262BF, exp 2021-09; C002KF, exp 2022-01; C030HT, exp 2022-02; C094LT, exp 2022-04; C275CW, exp 2022-10; C338CH, exp 2022-12; b) B122DX, exp 2021-05; B183GP, exp 2021-07; B262BE, exp 2021-09; C002KF, exp 2022-01; C030HT, exp 2022-02; C094LT, exp 2022-04; C275CW, exp 2022-10; C330BG, exp 2022-12 c) B122DY, exp 2021-05; B183GN, exp 2021-07; B262BF, exp 2021-09; C002KF, exp 2022-01; C030HT, exp 2022-02; C094LT, exp 2022-04;C156FF, exp 2022-06; C247JB, exp 2022-09; C338CH, exp 2022-12. d)B122DX, Exp 05/2021; B122DY , EXP 05-2021; B183GP, EXP 07-2021; B262BE, EXP 09-2021; B262BF, EXP 09-2021; C002KF, EXP 01-2022; C030HT, EXP 02-2022; C094LT, EXP 04-2022; C156FF, EXP 06-2022; C247JB, EXP 09-2022; C275CW, EXP 10-2022; C330BG, EXP 12-2022; e) B100JS, Exp 04/2021; B183GQ, EXP 07-2021; B255KZ, EXP 09-2021; C030HS, EXP 02-2022; C100AH, EXP 04-2022; C247JF, EXP 09-2022; f) B122DY , EXP 05-2021; B183GN, EXP 07-2021; B183GP, EXP 07-2021; B262BF, EXP 01-2022; C002KF, EXP 02-2022; C030HT, EXP 02-2022; C094LT, EXP 04-2022; C156FF, EXP 09-2022; C275CW, EXP 12-2022; C338CH, EXP 05-2022;
China Gel Inc is recalling CHINA_GEL (Camphor 3.00%, Menthol 5.00%) A TOPICAL PAIN RELIEVER, packaged as a) 2 OZ (56.8g) tube, due to CGMP deviations: Product being recalled as it was made in the same facility where contamination with B. cepacia was found in other products.. This is a Class I recall, indicating a high risk of serious health consequences. Based on FDA drug enforcement report.
Summary derived from FDA notice
Reason for Recall
As stated by FDA
CGMP deviations: Product being recalled as it was made in the same facility where contamination with B. cepacia was found in other products.
Recommended Action
Per FDA guidance
Consumers should stop using the product and contact the recalling firm, their healthcare provider, or return it to the place of purchase.
Verify this information on the official source
For complete details and official instructions, check the U.S. Food and Drug Administration (FDA) directly.
View official FDA recall noticePage updated: Jan 7, 2026